our practice
contact information
FromYourDoctor service powered by Vivacare
This service should not be used in place of a visit, call, consultation with or the advice of your healthcare provider.
Communicate promptly with your provider with any health related questions or concerns.
- Contact Us
- - Physicians & Staff
- - General Information
- - Office Hours
- - Driving Directions & Parking
- - Insurance Information
- - Payment Policies
- - Our Educational Services
- - Hospital Affiliations
- - Patient Forms
Norman Levine, MD
Norman Levine, MD
5639 E. Grant Rd ; Tucson, AZ 85712
(520) 615-3444
FAX: (520) 547-0489
derm318@gmail.com
Education
- College: University of Michigan, Ann Arbor, Michigan, September 1962 - May 1966 - B.A. degree
- Medical School: University of Michigan Medical School, September 1966 - June 1970 - M.D. degree
- Internship: Montefiore Hospital , Bronx, New York, 1970- 1971
- Residency: Albert Einstein College of Medicine, Division of Dermatology, 1975 - 1977
- Other Training: Research Fellow in Dermatology, Montefiore Hospital, 1973-1975
Work History
- Assistant Professor of Medicine, Albert Einstein College of Medicine, 1977-1978
- Assistant Professor of Medicine (Dermatology), University of Arizona Health Sciences Center, 1978 -1983
- Associate Professor of Medicine (Dermatology), University of Arizona Health Sciences Center, 1983 -1991
- Chief of Dermatology, University of Arizona Health Sciences Center, 1986-2003
- Professor of Medicine, University of Arizona Health Sciences Center, 1991-2006
- Private practice of dermatology; 2006-present
Certification:
- Medical License: Arizona, 1978
- Diplomate American Board of Dermatology, 1977
Military Service:
- Captain, MC USAF, General Medical Officer, Wright Patterson AFB, Ohio 1971-1973
Publications
• Levine N, Lazarus GS: Subcutaneous fat necrosis after paracentesis. Arch Dermatol. 112:993-994, 1975.
• Levine N, Hatcher VP, Lazarus GS: Proteinases of human epidermis: a possible mechanism for polymorphonuclear leukocyte chemotaxis. Biochem Biophys Acta. 52:458-467, 1976.
• Lazarus GS, Levine N, Vale M, Vale MB, Hatcher VB. Human chemotactic proteinase, in Rheumatoid Arthritis: Cellular Pathology and Pharmacology, (eds.), Gordon JL and Hazelman BL, North Holland, New York, 1977.
• Hatcher VB, Lazarus GS, Levine N, Burk PG, Yost , FJ, Jr.:.Characterization of a chemotactic and cytotoxic proteinase from human skin. Biochem Biophys Acta, 483:160-171, 1977.
• Lazarus GS, Hatcher VB and Levine N: Lysosomes and the skin. J Invest Dermatol. 65:259-271,1975.
• Levine N, Greenwald ES: Mucocutaneous side effects of cancer chemotherapy. Cancer Treatment Rev, 5:67-84, 1978.
• Kopec A , Levine N: Generalized connective tissue nevi in a patient with Down's Syndrome. Arch Dermatol, 115:623-624, 1979.
• Levine N, Freilich A , Barland P: Localized pemphigoid simulating dyshidrosiform dermatitis. Arch Dermatol 115:320-321, 1979.
• Levine N, Nagle RB: Immunofluorescence in the diagnosis and treatment of cutaneous disease. Ariz Med 36:356-358, 1979.
• Levine N: Topical corticosteroids. Ariz Med, 36:904-907, 1979.
• Levine N: Urticaria and hypocomplementemia with subepidermal bullae. New York State J Med 79:2073-2076, 1979.
• Levine N, Lynch PJ: Polyarteritis nodosa, in Current Therapy, Conn, HF, ed., Philadelphia, W.B. Saunders, p. 669-670, 1980.
• Levine N, Meyskens FL, Jr.: Topical vitamin A acid therapy for cutaneous metastatic melanoma. Lancet 2:224-226, 1980.
• Levine N, Lynch PJ: Comparison of halcinonide and diflorasone diacetate in short-term management of psoriasis. Cur Therap Res 28:303-308, 1980.
• Levine N: Dermatologic aspects of sports medicine. J Am Acad Dermatol 3:415-424, 1980.
• Lamberts R, Levine N: Current concepts of cutaneous melanoma. Ariz Med 37:775-779, 1980.
• Levine N: Topical Therapy: traditional agents and how to use them. Mod Med
• 48(16):48-62, 1980.
• Levine N: Diagnostic work-up of lupus erythematosus. J Dermatol All 4:11-14, 1981.
• Levine N: Clinical diagnosis of cutaneous melanoma. J Dermatol All 4:58-63, 1981.
• Levine N: Bacterial skin infections. Mod Med 49(7):26-34, 1981.
• Saied NK, Schwartz RA, Hansen RC, Levine N: Atypical familial benign chronic pemphigus. Cutis 27:666-669, 1981.
• Levine N: Friction blisters. Phys Sportsmed 10:84-92, 1982.
• Levine N, Queen L, Chalom A, Daniels L: Animal model of intracutaneous melanoma. J Invest Dermatol 78:191-193, 1982.
• Meyskens FL, Jr., Gilmartin E, Alberts DS, Levine N, et al: Activity of 13-cis-retinoic acid against squamous cancers and preneoplastic lesions. Canc Treat Rep 66:1315-1319, 1982.
• Levine N, Bangert J: Metastatic Crohn's disease. Arch Dermatol 118:1006-1009, 1982.
• Levine N, Queen L, Chalom A: An approach to the detection of melanomas by radiolabelled false precursors of melanin synthesis. Arch Dermatol 119:295-299, 1983.
• Kessler JF, Meyskens FL, Jr., Levine N, et al: Successful treatment of cutaneous T-cell lymphoma (mycosis fungoides) with 13-cis retinoic acid. Lancet 1:1345-1347, 1983.
• Draelos ZK, Levine N: Hyperthermic treatment of cutaneous malignancies. J Am Acad Dermatol 9:623-628, 1983.
• Allegretto EA, Kelly MA, Donaldson CA, Levine N, et al: High pressure liquid chromatographic detection of intracellular retinoid binding proteins from cultured cell and tumor cytosols. Biochem Biophys Res Comm. 116:76-81, 1983.
• Levine N, Miller RC, Meyskens FL, Jr.: Oral isotretinoin therapy for multiple squamous cell carcinomas and keratoacanthomas. Arch Dermatol 120:1215-1217, 1984.
• Levine N, Kettel LJ: Hyperthermic therapy of cutaneous cancer. Ariz Med 41:826, 1984.
• Levine N: Effects of topical retoinoic acid on intracutaneously implanted S91 melanoma in mice. J Invest Dermatol 85:89-92, 1985.
• Giese NA, Neary KE, Levine N, et al: Inhibition by retinoic acid of murine retrovirus-induced cellular transformation and tumor formation. JNCI 74:1135-1144, 1985.
• Levine N: Life-threatening dermatoses. Emerg Med Clin NA, 3:747-776, 1985.
• Jegasothy B, Jacobson C, Levine N, et al: Clobetasol proprionate versus fluocinoide cream in psoriasis and eczema. Int J Dermatol, 24:461-465, 1985.
• Edwards L, Alberts DS, Levine N: Clinical toxicity of low dose isotretinoin. Cancer Treat Rep 70:663-664, 1986.
• Meyskens FL, Edwards L, Levine N: Role of topical tretinoin in melanoma and dysplastic nevi. J Am Acad Dermatol, 15:822-825, 1986.
• Kessler JF, Jones SE, Levine N, et al: Isotretinoin in cutaneous helper T-cell lymphoma (mycosis fungoides). Arch Dermatol, 123:201-204, 1987.
• Hadley ME, Wood SH, Lemus-Wilson AM, Dawson BV, Levine N, et al: Topical application of a melanotropic peptide induces systemic follicular melanogenesis. Life Sci 49:1889-1895, 1987.
• Levine N, Lemus-Wilson A, Wood SH, et al: Stimulation of follicular melanogenesis in the mouse by topical and injected melanotropins. J Invest Dermatol 89:269-273, 1987.
• Draelos ZK, Levine N: Capacitive radiofrequency hyperthermia in the treatment of cutaneous murine melanoma. J. Invest Dermatol 89:518-522, 1987.
• Levine N: Cutaneous manifestations of systemic disease. Triangle 26:185-199, 1987.
• Dorr RT, Dawson BV, Al-Obeidi F, Hadley ME, Levine N, Hruby VJ: Toxicologic studies of a superpotent a-melanotropin, (Nle4,D-Phe7)-a-MSH. Investigational New Drugs 6:251-258, 1988.
• Edwards L, Meyskens FL, Levine N: Effect of oral isotretinoin on dysplastic nevi. J Am Acad Dermatol 20:257-260, 1989.
• Levine N, Don SA, Klewer JA, et al: Radiofrequency hyperthermia and topical retinoic acid therapy in murine melanoma. Am J Med Sci 297:285-290, 1989.
• Don SA, Klewer SE, Levine N: Radiofrequency hyperthermia therapy of malignant melanoma: a comparison of fractionated versus single-dose treatments. J Dermatol Sur Oncol 15:845-849, 1989.
• Levine N, Don SA, Owens C, et al: The effects of bergapten (5-MOP) and sunlight on cutaneous pigmentation. Arch Dermatol 125:1225-1230, 1989.
• Dawson BV, Hadley ME, Levine N, Kreutzfeld KL, et al: In vitro transdermal delivery of a melanotropic peptide through human skin. J Invest Dermatol 94:432-435, 1990.
• Edwards L, Levine N, Smiles KA. The effect of topical interferon alfa 2-b on actinic keratosis. J Dermatol Surg Oncol 16:446-449, 1990.
• Levine N, Earle M, Wilson S: Controlled localized heating and isotretinoin effects in canine squamous cell carcinoma. J Amer Acad Dermatol 23:68-72, 1990.
• Levine N. Drug-induced cutaneous photosensitivity. Drug Ther 20:44-57, 1990.
• Levine N, Rothschild JG: Treatment of mycobacterium chelonae infection with controlled localized heating. J Am Acad Dermatol 24:867-870, 1991.
• Levine N, Sheftel SN, Eytan T, et al: Induction of skin tanning by subcutaneous administration of a potent synthetic melanotropin. JAMA 266:2730-2736, 1991.
• Olsen EA, Katz HI, Levine N, et al: Tretinoin emollient cream: a new therapy for photodamaged skin. J Am Acad Dermatol 26:215-224, 1992.
• Levine N: Cutaneous leishmaniasis treated with controlled localized heating. Arch Dermatol 128:759-761, 1992.
• Stern P, Levine N: Controlled localized heat therapy in cutaneous warts. Arch Dermatol 128:945-948, 1992.
• Ehlsen KR, Hadley ME, Levine N, et al. Effects of melanotropic peptide on melanoma cell growth. Pigment Cell Res 5:219-223, 1992.
• Hadley ME, Sharma SD, Hruby VJ, Levine N, et al: Melanotropic peptides for therapeutic and cosmetic tanning of the skin. Melanotropic Peptides , Ann N Y Acad Sci, 680:424-439, 1993.
• Wong P, Bangert J, Levine N: A papulovesicular eruption in a man receiving chemotherapy for metastatic melanoma . Arch Dermatol, 129:232-236, 1993.
• Ertl, GA, Levine, N, Kligman, AM: A comparison of the efficacy of topical tretinoin and low-dose oral isotretinoin in rosacea. Arch Dermatol, 130:319-324, 1994.
• Lesher, J, Levine, N, Treadwell P: Fungal skin infections. Patient Care, 28:16-44, 1994.
• Savin, R, Atton, AV, Bergstressor, PR, Elewski, B, Jones, HE, Levine, N, et al.: Efficacy of terbinifine 1% cream in the treatment of moccasin-type tinea pedis: Results of placebo-controlled multicenter trials. J Am Acad Dermatol, 30:663-667, 1994.
• Levine, N.: Dermatologic aspects of sports medicine. Dermatol Nursing, 6:179-188, 1994.
• Johnson, PD, Dawson, BV, Dorr, RT, Hadley, ME, Levine, N, et al.: Coat color darkening in a dog in response to a potent melanotropic peptide. Am J Vet Res, 55:1593-1596, 1994.
• Moon, TE, Levine, N., Cartmel, B, et al.: Design and recruitment for retinoid skin cancer prevention (SKICAP) trials. Canc Epidem Biomarkers Prev, 4:661-669, 1995
• Dorr, RT, Lines, T, Levine, N, et al.: Pilot phase I trial of a superpotent cyclic melanotropic peptide in 3 normal volunteers. Life Sciences, 58:1777-1784, 1996.
• Einspahr, J, Alberts, DA, Aickin, M, Welch, K, Bozzo, P, Levine, N, et al. Evaluation of proliferating cell nuclear antigen (PCNA) as a surrogate endpoint biomarker in actinic keratosis, adjacent, normal-appearing, and non-sun exposed skin samples. Canc Epid Biomarkers Prev, 5:343-348, 1996.
• Levine, N. Kligman, AM: A sequential combination of topical tretinoin and a potent topical corticosteroid improves photodamaged facial skin. J Dermatol Treat, 7:23-27, 1996.
• Edwards, L, Glass, F, Levine, N, Sober, A.J. Melanoma: a strategy for detection and treatment. Patient Care, 28:126-153, 1996.
• Fuciarelli, K, Levine, N . Rhytides-new approaches to old wrinkles. West J. Med, 164:517-518, 1996.
• Ugwu, SO, Blanchard, J, Dorr, RT, Levine, N, et al.: Skin pigmentation and pharmacokinetics of melanotan-I in humans. Biopharm Drug Disp, 18:259-269, 1997.
• Shupack, J, Abel, E, Bauer, E, Brown, M, Drake, L, Freinkel, R, Guzzo, C, Koo, J, Levine, N, et al. Cyclosporine as maintenance therapy in patients with severe psoriasis. J Am Acad Dermatol 36:423-432, 1997.
• Levine, N. Aging skin - the skin cancer time bomb, Skin Cancer foundation Journal 15, 26-27, 1997.
• Olsen, EA, Katz, HI, Levine, N, et al. Tretinoin emollient cream for photodamaged skin: results of 48-week, multicenter, double-blind studies of topical therapy, J Amer Acad Dermatol 37:217-226, 1997
• Olsen, EA, Katz, HI, Levine, N, et al. Sustained improvement in photodamaged skin with reduced tretinoin emollient cream treatment regimen: effect of once-weekly and three-times-weekly applications, J Amer Acad Dermatol 37:227-230, 1997
• Moon, TE, Levine, N, Cartmel, B, et al. Use of retinol to prevent squamous cell skin cancer in moderate-risk subjects, Canc Epidem Biomarkers Prev. 6:949-956, 1997.
• Levine, N., Moon, T.E., Cartmel, B., et al. Trial of retinol and isotretinoin in skin cancer prevention, Canc Epidem Biomarkers Prev 6:957-961, 1997.
• Atkin, D.H., Levine, N., Walter, F.G. Single patch of hair at a denervated site in a patient with alopecia universalis, J Amer Acad Dermatol, 37;796-797, 1997
• Romine, K, Levine, N, Kligman, A, Prevention of tumor promotion by topical tretinoin in early photodamage of the face, J Dermatol Treat, 8:544-548, 1997.
• Scher, R.K., Breneman, D., Rich, P., Savin, R.C., Feingold, D.S., Konnikov, N., Shupack, J.L., Pinnell, S, Levine, N., et al. A placebo-controlled, randomized, double-blind trial of once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the toenail. J Amer Acad Dermatol 38 (part 2) S77-86, 1998.
• Drake, L., Babel, D., Stewart, D.M., .............Levine, N., et al. A placebo-controlled, randomized, double-blind trial of once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the fingernail. J Amer Acad Dermatol 38 (part 2) S 87-96, 1998.
• Rich, P, Scher, R.K., Breneman, D.,..........Levine, N., et al. Pharmacokinetics of three doses of once-weekly fluconazole (150, 300, and 450 mg) in the treatment of distal subungual onychomycosis of the toenail. J Amer Acad Dermatol 38 (part 2) S103-109, 1998.
• Savin, R.C., Drake, L., Babel, D.,...........Levine, N., et al. Pharmacokinetics of three doses of once-weekly fluconazole (150, 300, and 450 mg) in the treatment of distal subungual onychomycosis of the fingernail. J Amer Acad Dermatol 38 (part 2) S110-116, 1998.
• Levine, N. Role of retinoids in skin cancer treatment and prevention. J Am Acad Dermatol 39 (Part 3):S62-S66, 1998.
• Wessells, H., Fucciarelli, K., Hansen, J., Hadley, M.E., Hruby, V. J., Dorr, R, Levine, N. Synthetic melanotropicpeptide initiates erections in men with psychogenic erectile dysfunction: double-blind crossover placebo controlled study. J Urol, 160:389-393, 1998.
• Cartmel, B, Moon, T, Levine, N. The effects of long term intake of retinol on selected clinical and laboratory parameters. Am J Clin Nutr, 69:937-943, 1999.
• Silvis, NG, Levine, N, Pulse dosing of thioguanine in recalcitrant psoriasis. Arch. Dermatol. 135:433-437. 1999.
• Krupinski, EA, LeSuer, B, Ellsworth, L, Levine., N et al. Diagnostic performance and image quality assessment in teledermatology. SPIE, 3663:199-206, 1999.
• Krupinski, E., LeSueuer, B, Ellsworth, L.E., Levine, N., et al. Diagnostic accuracy and image quality using a digital camera for teledermatology. Telemed J. 5:257-263, 1999.
• Lee, J, Jiang, S, Inserra, P, Sepulveda, RT, Zhang, Z, Levine, N, et al., Carotenoid supplementation reduces erythema in human skin after solar radiation exposure, PSEBM 223:170-174, 2000.
• Buller, D, Burgoon, M, Hall, J, Levine, N, et al, Using language intensity to increase the success of a family intervention to protect children from ultraviolet radiation Preventive Med 30:103-114, 2000.
• Wessells H, Levine N, Hadley ME, Dorr R, Hruby V, Melanocortin receptor agonists, penile erection, and sexual motivation: human studies with Melanotan II, Int J Impot Res 12 Suppl 4:S74-79, 2000
• Buller, DB, Burgoon, M, Hall, JR, Levine, N, et al, Long term effects of language intensity in preventive messages on planned family solar protection. Health Communication, 12:261-275, 2000
• Cartmel, B, Moon, TE, Levine, N, Alberts, DA. Predictors of inactivation and reasons for participant inactivation during a skin cancer chemoprevention study. Cancer Epidem. Biomarkers and Prev 9:999-1002, 2000.
• Dorr, RT, Dvorakova, K, Brooks, C, Lines, R, Levine, N, el al.: Eumelanin expression and tanning is induced by [Nle4-D-Phe7]-_-MSH1-13 in human skin. Photochem and Photobiol 72:526-532, 2000.
• Behr, F, Levine, N, Bangert, J Lichen amyloidosis associated with atopic dermatitis: clinical resolution with cyclosporine, Arch Dermatol 137:553-55,2001.
• Paniker, U., Levine, N. Dapsone and sulfapyridine, Dermatologic Clinics 19:79-86, 2001.
• Radomsky, C, Levine, N. Thalidomide, Dermatologic Clinics 19:87-103, 2001.
• Tennyson, H, Levine, N. Neurotropic and Psychotropic drugs in dermatology, Dermatologic Clinics 19:179-197, 2001.
• Nylrady, J, Bergfeld, W, Ellis, C, Levine, N, et al. Tretinoin cream 0.02% for treatment of photodamaged facial skin: a review of 2 double-blind clinical studies Cutis 88:135-142, 2001.
• Krupinski, E, Barker, G, Rodriguez, G, Engstrom, M, Levine, N, et al. Telemed Journal 8:143-147, 2002.
• Levine, N, Kunkel, M, Nguyen, T, Ackerman, L. Emergency department dermatology Curr Prob Dermatol 14:183-220, 2002.
• Salasche SJ, Levine N, Morrison L Cycle therapy of actinic keratoses of the face and scalp with 5% topical imiquimod cream: an open-label trial J Am Acad Dermatol 47:571-577, 2002.
• Krupinski E. Barker G. Rodriguez G. Engstrom M. Levine N. Lopez AM. Weinstein RS. Telemedicine versus in-person dermatology referrals. Telemedicine Journal & E-Health. 8(2):143-147, 2002.
• Krupinski, EA, Engstrom, M, Barker, G, Levine, N, et al The challenges of following patients and assissing outcomes in teledermatology J of Telemed and Telecare 10:21-24, 2004
• Tee, R, Levine, N Drugs targeting tumour necrosis factor-α in psoriasis, Curr. Med Lit, 9:1-6, 2004.
• Alberts, DS, Ranger-Moore, J, Einspahr, J, Saboda, K, Bozzo, P, Yun Liu, S, Xiao-Chun, X, Lotan, R, Warneke, J, Salasche, S, Levine, N, et al. Safety and Efficacy of Dose Intensive Oral Vitamin A in Subjects with Sun-Damaged Skin, Clin Canc Res, 10:1875-1880, 2004.
• Dorr, RT, Ertl, G, Levine, N, et al, Effects of a Superpotent Melanotropic Peptide In Combination with Solar Ultraviolet Radiation on Tanning of the Skin in Human Volunteers, Arch Dermatol 140:827-835, 2004.
Abstracts
• Hatcher VB, Levine N, Lazarus GS: Characterization of the neutral proteases from human skin. Fed Proc 34:484, 1975.
• Hatcher VB, Levine N, Lazarus GS: Characterization of proteolytic enzymes extracted fromhuman skin. Clin Res 23:229A, 1975.
• Levine N: Detection of melanomas by radiolabelled false precursors of melanin synthesis. Clin Res 29:604A, 1981
• Levine N, Fredenberg M, Jones A, et al: Incidence of metastatic spread of intracutaneous melanoma after subtotal biopsy. Clin Res 31:148A, 1983.
• Levine N: The effects of topical retinoic acid on intracutaneously implanted S91 melanoma in mice. Clin Res 32:140A, 1984.
• Draelos ZK, Levine N: Radiofrequency hyperthermia treatment of human squamous cell carcinoma in a nude mouse model. Clin Res 33:154A, 1985.
• Meyskens FL, Levine N, Kessler SF, et al: High response rate of advanced cutaneous T-cell lymphoma (mycosis fungoides) to 13-cis retinoic acid (isotretinoin). Clin Res 34:162A, 1986
• Levine N, Hadley ME, Lemus-Wilson A, et al: Stimulation of murine follicular melanogenesis by systemic and topical melanotropins. Clin Res 34:161A, 1986.
• Draelos ZK, Levine N: Retinoic acid and fractionated radiofrequency hyperthermia in the treatment of murine melanoma. J Invest Dermatol 88:486, 1987.
• Klewer S, Don S, Levine N: Fractionated radiofrequency hyperthermia in the treatment of murine melanoma. Clin Res 36:120A, 1988.
• Levine N, Sheftel SN, Ertl GA, Hadley ME. Induction of skin tanning by the subcutaneous administration of a potent synthetic melanotropin. J Invest Dermatol 96:549, 1991.
• Levine N. Sun, melanogenesis, and cytokines. Photochem Photobiol 59:3S, 1994.
• Dorr, RT, Levine, N, Hadley, ME, et al., Use of superpotent synthethic melanotropins to prevent skin cancer. Clin Oncol Soc Aust, 1994.
• Wessells, H, Fuciarelli, K, Hansen, J, Dorr, R, Levine, N. Melanotropic peptide for the treatment of psychogenic erectile dysfunction: double blind crossover vehicle controlled study. J Impotence Res 8:147, 1996.
• Krupinski, A, LeSuer, B, Ellsworth, L, Levine, N, et al. Diagnostic performance and image quality assessment in teledermatology (1999)
• Watson, R, Lee, J, Jiang, S, Levine, N, et al. Carotenoid and pycnogenol supplementation reduces erythema in human skin after simulated solar radiation. J Invest Dermatol 114:841, 2000.
Monographs and book chapters
• Levine N, Conrad KA: Systemic Therapy, in Dermatology: A Clinical Perspective, Cligett, Greenwich, CT 1983.
• Levine N: Normal Pigmentation and Pigment Cell Biology, in Practice of Pediatrics, Kelley, VC (ed.), Chapter 28, p. 1-8, 1986.
• Levine N: Pigmentary Abnormalities in Pediatric Dermatology, in Pediatric Dermatology, Schachner LA, Hansen RC (eds), pp. 529-573, 1988.
• Levine N, Dawson B: "Mouse model of Follicular Melanogenesis" in Models of Dermatology, Vol4 Maibach HI, Lowe NJ (eds), p 233-239, 1989.
• Levine N, Owens C, Kligman A, et al: Effectiveness and safety of bergapten in sunlight-induced cutaneous pigmentation, in Psoralens, Fitzpatrick TB, Forlot P, et al. (eds) p 73-80, 1989.
• Levine N: Dermatologic Problems Mandating Admission in Current Therapy in Emergency Medicine, Vol 2, Callaham, M (ed) p 886-889, 1991.
• Hadley ME, Hruby VJ, Levine N, et al: A melanotropic peptide induces pigmentation (tanning) ofhuman skin, in Proceedings of the Twentieth American Peptide Symposium, p 429-430,1992.
• Levine N: Local destruction of actinic keratoses, in Actinic Keratoses, Goltz, RW (ed), p 23-26, 1992.
• Levine N: Pigmented Lesions; Urticaria/generalized pruritus/palpable purpura, in Decision Making in Medicine, Greene HL, et al. (eds), p 84-93, 1993.
• Levine, N: Pigmentary Abrormalities in Pediatric Dermatology, Schachner, L.N., Hansen. R.C., pp. 539-582, 1995
• Levine N: Pigmentary Disorders, in Conn's Current Therapy, Rakel, RE, (ed), 852-854, 1998.
• Andonyan, A., Levine, N. Infectious skin disorders, in Clinical Medicine of Native Americans Infectious Skin Disorders, in Primary Care of Native American Patients: Diagnosis, Therapy, and Epidemiology, Galloway, JM, Goldberg, BW, Alpert, JS (eds), 103-112, 1998
• Hadley, M.E., Hruby, V.J., Blanchard, J., Dorr, R.C., Levine, N., et al. Discovery and development of novel melanogenic drugs: Melanotan-I (MT-I) and Melanotan-II (MT-II) in Integration of Pharmaceutical Discovery and Development: Case Studies, Borchardt, C., et al (eds), pp. 575-595, 1998.
• Levine, N, Falk, CS, Rubenzik, R, Acquired epidermal hypermelanoses, in The Pigmentary System, Nordlund, JJ, et al (eds), pp 829-857, 1998.
• Levine N: Disorders of Pigmentation, in Current Pediatric Therapy, Burg, FD, Ingelfinger, JR, et al (eds), pp. 977-978, 1999.
• Levine, N, Baron, J, Acanthosis Nigricans in: James, WD, Elston, D (Chief eds.), eMedicine Dermatology, St. Petersburg: eMedicine Corporation, 2000.
• Levine, N, Baron, J, Black Heel in: James, WD, Elston, D (Chief eds.), eMedicine Dermatology, St. Petersburg: eMedicine Corporation, 2000.
• Levine, N, Swan, B, Syphilis in: James, WD, Elston, D (Chief eds.), eMedicine Dermatology, St. Petersburg: eMedicine Corporation, 2000.
• Levine, N, Pigmentary disorders in Rakel, R, Bope, R (eds), Conn’s Current Therapy 2003, pp. 937-939, 2003.
• Morelli, J, Taieb, A, Levine, N, et al., Pigmentary abnormalities, Hansen, RC, Schachner, L (eds), in Pediatric Dermatology, pp.491-524, 2003.
• Trout, C, Levine, N, Chang, MW, Disorders of Hyperpigmentation, in Bolognia, J, Jorizzo, Rapini, R, et al (eds), Dermatology, pp. 975-995, 2003.
• Levine, N Pigmentary Abnormalities in Rakel, R, Bope, R (eds), Conn’s Current Therapy 2007 (in press)
Books
• Levine N: Pigmentation and Pigmentary Abnormalities , CRC Press, Boca Raton, 1993.
• Levine N: Skin Healthy: Everyone's Guide to Great Skin, Taylor Publishing, Dallas, 1995.
• Levine N, Levine CC: Dermatology Therapy, A to Z, Springer, Berlin, 2004.
• Levine N. Dermatology Diseases and Therapy, Cmabridge University Press, New York, 2007.
Other Publications
• Levine, N, Mesel, E, Dermatology For Medical Students and Residents (CD-ROM format), CMC Research, Portland, OR, 1998.
• Mesel, E, Levine, N, Dermatology for Health Professionals (CD-ROM format), Medifor, Inc., Port Townsend, WA, 1999
• Levine, N. (ed.) Systemic Dermatologic Therapy in Dermatologic Clinics Vol 19, 2001.
• Levine, N, Checklist in Dermatology (PDA format), PocketMedicine, New York, 2003.
• Levine, N, Dermatology Diseases and Therapy (PDA format), PocketMedicine, New York, 2004.
This site complies with
the
HONcode standard for trustworthy health information: verify here.
View Content Policy